Idexx Laboratories (IDXX) Short-Term Debt issuances (2020 - 2026)

Idexx Laboratories' Short-Term Debt issuances history runs 5 years deep, the most recent figure standing at $132.0 million for Q1 2026.

• In Q1 2026, Short-Term Debt issuances rose 89.93% year-over-year to $132.0 million; the TTM figure through Mar 2026 stood at $210.5 million (up 202.88% YoY), while the FY2025 annual figure was $148.0 million, changed N/A from the prior year.
• Short-Term Debt issuances for Q1 2026 stood at $132.0 million, up from -$57.0 million in the prior quarter.
• The five-year high for Short-Term Debt issuances was $326.5 million in Q1 2022, with the low at -$167.5 million in Q2 2023.
• The 4-year median for Short-Term Debt issuances is $4.0 million (2022), against an average of $38.0 million.
• The sharpest annual moves came in 2023 and 2026: Short-Term Debt issuances tumbled 179.38% in 2023, then jumped 89.93% in 2026.
• Idexx Laboratories' Short-Term Debt issuances stood at -$54.0 million in 2022, then soared by 74.07% to -$14.0 million in 2023, then sank by 307.14% to -$57.0 million in 2025, then soared by 331.58% to $132.0 million in 2026.
• Business Quant data shows IDXX's Short-Term Debt issuances at $132.0 million in Q1 2026, -$57.0 million in Q4 2025, and -$124.0 million in Q3 2025.